Organizations
Contact: Kathy Brodeur-Robb kbrodeur@cha.ab.ca
Contact: Fay Wilkinson - fwilkins@ucalgary.ca
Contact: Leslie Stewart - healthtrials@hsc.mb.ca
Contact: April Hughes ahughes@sbgh.mb.ca
Website: www.sbgh.mb.ca
Contact: Linda Purchase - lpurchas@mun.ca
Website: www.hccsj.nf.ca
Contact: Lisa Underwood www.cdha.nshealth.ca
Website: www.clinicaltrialsdivision.com
Website: www.lctrg.com
Website: www.socra.org Canada's Research-Based Pharmaceutical Companies www.canadapharma.org
Studies
- Clinical Trials Listing Service.
- The purpose of this site is to inform potential subjects about studies. It is the first comprehensive listing of federally funded trials in the United States. This site is expected to become the major online clearinghouse for private and publicly funded trials, and in the process, to help trial sites and other businesses get work, and track the industry. Resources
- At this site you can access a letter written by CBER's director, Kathryn Zoon, to all sponsors and principal investigators of gene therapy INDs to clarify serious adverse events (SAE) reporting requirements.
- It helps researchers determine what should go into a protocol, how to provide safeguards for children, pregnant women and genetics research. It includes forms for IRB review, guidelines for informed consent documents, sample IRB reports, an all-day training seminar for investigators and a two-hour "nuts and bolts" education session for investigators.
- Provides two new Standard Operating Procedures and Policies to notify NIH when FDA has received adverse event reports and protocol changes. ICH/GCP
published by Health Canada. Education